APA (7th ed.) Citation

CM, V., GR, d. S. E. S., MVH, S., LAB, C., JR, X., VC, d. G., . . . BC, C. (2024). Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses. Memorias do Instituto Oswaldo Cruz, 119, e240094. https://doi.org/10.1590/0074-02760240094

Chicago Style (17th ed.) Citation

CM, Vianna, et al. "Homologous Equivalence Study of Immunogenicity After Third Dose of Covid-19 Vaccine (recombinant) with an Interval of Six Months After the Second Dose, Comparing the Interval of Eight and 12 Weeks Between the First Two Doses." Memorias Do Instituto Oswaldo Cruz 119 (2024): e240094. https://doi.org/10.1590/0074-02760240094.

MLA (9th ed.) Citation

CM, Vianna, et al. "Homologous Equivalence Study of Immunogenicity After Third Dose of Covid-19 Vaccine (recombinant) with an Interval of Six Months After the Second Dose, Comparing the Interval of Eight and 12 Weeks Between the First Two Doses." Memorias Do Instituto Oswaldo Cruz, vol. 119, 2024, p. e240094, https://doi.org/10.1590/0074-02760240094.